Guidelines for Pharmacotherapy of Schizophrenia Flashcards

1
Q

Canadian schizophrenia guidelines stresses the importance of…

A

Earlier treatment of symptoms
Need for greater attention to physical care
Greater emphasis on recovery + providing personalized care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

____ play a central role in recommendations related to pharmacotherapy

A

Antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

It is important to recognize that psychotic symptoms can…

A

Wax and wane during the course of illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Early detection and treatment of a first episode of psychosis is crucial because…

A

Linked with decreased depression, increased mood/cognitive scores, and improved overall function at 10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Longer durations of untreated psychosis results in…

A

Decreased response to treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pharmacotherapy given for a first episode of psychosis is…

A

Usually a 2nd/3rd gen AP - choose agent based on AE profile, drug interactions, cost; use lowest effective dose

Compared to 1st gen: Lower AE, lower rates of discontinuation, equal efficacy
LAIA may lower relapse risk vs. oral therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment duration for a 1st episode of psychosis is…

A

Minimum of 18 months, but indefinite therapy is very reasonable (risk of relapse after 1st episode is VERY high)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Once a specific AP is selected it should be initiated and further titrated based on…

A

Efficacy and tolerability with a target dose (on the lower end of the dose range)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

An adequate trial with an AP is considered…

A

Minimum of 6 weeks at the optimally tolerated dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Upon an acute exacerbation, we should first screen for…

A

Non-adherence, substance use, drug interactions

Since these would not constitute AP treatment failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Options to consider regarding pharmacotherapy for an acute exacerbation of psychosis includes…

A

Increasing dose of current AP
Changing AP if treatment failure; trial for 6-8 weeks to determine effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Non-psychotic symptoms, such as mood changes may…

A

Necessitate treatment with non-AP medications; mood stabilizers, AD’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Maintenance treatment with AP’s contribute to…

A

Relapse prevention and decreased hospitalization rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Psychosis and schizophrenia is often co-morbid with…

A

Substance use disorder

Difficult to determine whether psychosis came first, or substances causing psychosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Factors that may indicate an underlying psychotic disorder, rather than a substance causing psychosis includes…

A

Psychosis persisting with abstinence
Sx’s not aligning with type/amount of substance
Family hx of psychosis
Typical positive symptoms of schizophrenia, presence of negative/cognitive symptoms (prodromal period)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Does psychosis + substance use disorder change treatment options?

A

No evidence of benefit for one AP over another for psychosis + SUD

17
Q

Treatment-resistance schizophrenia is defined as…

A

2+ positive symptoms of moderate severity or 1 positive symptoms of severe severity, after 2+ adequate AP trials

18
Q

To see if an AP trial is confirmed a failure, we should confirm…

A

Adherence
Co-substance use, drug interactions
Dose assessment

19
Q

First-line therapy for treatment-resistant schizophrenia is…

A

Clozapine

20
Q

Clozapine-resistant schizophrenia is defined by…

A

Symptoms remaining with 8-12 weeks at doses above 400mg/day, and trough levels above 350ng/mL (OD) or 250ng/mL (BID)

Clozapine levels are not routinely done unless there are concerns about non-response, non-adherence, AE’s, or drug interactions

21
Q

What could be tried for clozapine resistant schizophrenia?

A

Multiple clozapine augmentation strategies (limited consensus)
No consistent evidence to support high dose AP, switching AP’s, or AP polypharmacy. Polypharmacy may be useful for some but increase AE’s

22
Q

A combination of clozapine and aripiprazole LAI in clozapine-resistant schizophrenia may help by…

A

Decrease rate of psychiatric hospitalization vs. clozapine monotreatment

23
Q

Non-pharm options for clozapine-resistant schizophrenia includes…

A

ECT
Trans magnetic stimulation
CBT